IRIS
MERLINI, GIAMPAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.835
AS - Asia 13.606
EU - Europa 9.788
SA - Sud America 1.716
AF - Africa 487
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 17
AN - Antartide 1
Totale 42.479
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.457
CN - Cina 6.279
SG - Singapore 3.195
IE - Irlanda 2.557
HK - Hong Kong 1.493
BR - Brasile 1.265
VN - Vietnam 1.248
RU - Federazione Russa 1.155
FI - Finlandia 1.106
UA - Ucraina 1.078
DE - Germania 1.048
FR - Francia 664
IT - Italia 663
SE - Svezia 489
GB - Regno Unito 474
IN - India 328
ZA - Sudafrica 281
CA - Canada 188
AR - Argentina 154
BD - Bangladesh 153
JP - Giappone 126
MX - Messico 119
IQ - Iraq 112
TR - Turchia 95
PL - Polonia 82
PK - Pakistan 77
NL - Olanda 74
BE - Belgio 72
CO - Colombia 69
VE - Venezuela 63
ES - Italia 60
ID - Indonesia 59
EC - Ecuador 54
AT - Austria 52
SA - Arabia Saudita 45
UZ - Uzbekistan 44
MA - Marocco 43
PH - Filippine 43
CL - Cile 32
KE - Kenya 32
LT - Lituania 31
CZ - Repubblica Ceca 30
IR - Iran 29
PY - Paraguay 29
AE - Emirati Arabi Uniti 26
JO - Giordania 26
MY - Malesia 25
TN - Tunisia 22
AU - Australia 21
IL - Israele 20
JM - Giamaica 20
EG - Egitto 18
GR - Grecia 18
KZ - Kazakistan 18
ET - Etiopia 17
MU - Mauritius 17
NP - Nepal 17
AL - Albania 16
BO - Bolivia 16
UY - Uruguay 16
DZ - Algeria 15
PE - Perù 15
AZ - Azerbaigian 14
KG - Kirghizistan 14
KR - Corea 14
PT - Portogallo 13
LB - Libano 12
LV - Lettonia 12
RO - Romania 12
TH - Thailandia 12
DK - Danimarca 11
BG - Bulgaria 10
EU - Europa 10
HU - Ungheria 10
PA - Panama 10
PS - Palestinian Territory 9
HR - Croazia 8
NI - Nicaragua 8
OM - Oman 8
SY - Repubblica araba siriana 8
AM - Armenia 7
CH - Svizzera 7
NZ - Nuova Zelanda 7
CY - Cipro 6
DO - Repubblica Dominicana 6
EE - Estonia 6
LK - Sri Lanka 6
NG - Nigeria 6
SN - Senegal 6
BH - Bahrain 5
CR - Costa Rica 5
GA - Gabon 5
MD - Moldavia 5
RS - Serbia 5
AO - Angola 4
BB - Barbados 4
BN - Brunei Darussalam 4
GE - Georgia 4
HN - Honduras 4
MM - Myanmar 4
Totale 42.391
Salva come PNG Salva come JPEG
Città #
Dublin 2.549
Chandler 2.425
Singapore 1.594
Jacksonville 1.523
San Jose 1.502
Ashburn 1.488
Hong Kong 1.457
Nanjing 1.319
Dallas 1.217
Beijing 1.017
Boardman 695
Nanchang 564
Princeton 522
Lawrence 488
Lauterbourg 471
Wilmington 471
Ho Chi Minh City 427
Shenyang 403
Los Angeles 399
Medford 395
Hebei 380
Helsinki 349
Changsha 343
Hanoi 311
Jiaxing 304
Ann Arbor 276
Tianjin 247
Johannesburg 235
Hangzhou 223
New York 217
Buffalo 213
Redondo Beach 191
Moscow 190
Munich 180
Shanghai 161
Milan 135
Pavia 125
São Paulo 124
Woodbridge 111
Tokyo 107
Norwalk 100
Santa Clara 96
Orem 80
Da Nang 79
Chicago 78
Frankfurt am Main 77
Turku 74
Toronto 69
Brussels 68
Warsaw 68
Piscataway 67
Chennai 64
Verona 61
Fairfield 60
London 59
Brooklyn 58
Seattle 58
Montreal 54
Guangzhou 53
Des Moines 49
Denver 48
Stockholm 48
The Dalles 48
Zhengzhou 48
Baghdad 47
Nuremberg 46
Council Bluffs 44
Ningbo 44
Atlanta 43
Rio de Janeiro 43
Washington 43
Haiphong 42
Falkenstein 41
Houston 39
San Francisco 39
Mexico City 38
Amsterdam 37
Tashkent 37
Manchester 35
Pune 35
Boston 32
Phoenix 32
Hải Dương 30
Jinan 30
Ankara 28
Belo Horizonte 27
Biên Hòa 27
Kunming 27
Nairobi 27
Poplar 27
Brasília 25
Curitiba 25
Dhaka 25
Mumbai 24
Vienna 24
Charlotte 23
Lahore 22
Rome 22
Amman 21
Medellín 20
Totale 28.083
Salva come PNG Salva come JPEG
Nome #
Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview. 204
A novel method for proteomic analysis of immunoglobulin light chains and attribution to a germline gene-based family 161
Fibrillazione atriale e amiloidosi cardiaca AL: un connubio intrigante 156
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 154
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis 147
Liver biopsy discloses a new apolipoprotein AI hereditary amyloidosis in several unrelated Italian families 146
Valore prognostico della presenza di bassi voltaggi elettrocardiografici nei pazienti affetti da amiloidosi AL 145
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 142
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. 137
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. 136
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 135
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 133
Functional correlates of N-terminal natriuretic peptide type B (NT-proBNP) response to therapy in cardiac light chain (AL) amyloidosis 133
Amyloid typing: immunoelectron microscopy 132
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 129
AMICA: an electronic patient record specifically designed for an amyloidosis network 129
Advantages of the lognormal approach to determining reference change values for N-terminal propeptide B-type natriuretic peptide 129
A Strategy for Synthesis of Pathogenic Human Immunoglobulin Free Light Chains in E-coli 128
Abnormalities in thrombin-antithrombin pathway in primary systemic amyloidosis. 128
Heavy chain disease can be detected by capillary zone electrophoresis. 128
Amyloidogenic light chains induce human cardiac fibroblast toxicity through alteration of mitochondrial functionality 128
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis 127
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure. 127
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis 127
AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies 126
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 126
Characterization of the two unique human anti-flavin monoclonal immunoglobulins. 125
The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity 125
Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. 123
Bevacizumab treatment followed by maintenance in life-threatening POEMS syndrome. 123
A patient with AL amyloidosis with negative free light chain results 123
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays 123
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis 123
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy 123
Acute phase proteins and prognosis in multiple myeloma. 123
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. 122
Reasoning with Effects of Clinical Guideline Actions Using OWL: AL Amyloidosis as a Case StudyKnowledge Representation for Health-Care 122
Obstructive intramural coronary amyloidosis: a distinct phenotype of cardiac amyloidosis that can cause acute heart failure. 121
A novel approach for the purification and proteomic analysis of pathogenic immunglobulin free light chains from serum 121
4'-iodo-4'-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters. 120
Structural characterization of kappa II Inc, a new amyloid immunoglobulin 120
International prognostic scoring system for Waldenstrom macroglobulinemia 120
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis 120
Amyloid Diseases at the Molecular Level: General Overview and Focus on AL Amyloidosis 120
Cardiac light chain amyloidosis: The role of metal ions in oxidative stress and mitochondrial damage 120
Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients 119
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 119
Abnormalities in thrombin-antithrombin pathway in AL amyloidosis. 119
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis 119
AMYLOIDOSIS AL 118
“Separation and quantification of two beta2-microglobulin isoforms”. 118
Nutritional counseling improves quality of life and preserves body weight in systemic immunoglobulin light-chain (AL) amyloidosis 118
Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis. 118
A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis 118
Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosis 118
Autologous stem cell transplantation following heart transplantation for AL amyloidosis 117
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients 117
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis 116
Nutritional status evaluation of patients affected by al amyloidosis: a pilot study 115
Clotting alterations in primary systemic amyloidosis. 115
Waldenstrom macroglobulinemia 115
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis 115
4'-Iodo-4'-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid 115
Analysis of Vlambda-Jlambda expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambda III) as a new amyloid-associated germline gene segment 115
Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. 115
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 114
Metodo per la separazione e la quantificazione di due conformazioni di beta-2-microglobulina in equilibrio dinamico 114
ATR-FTIR spectroscopy supported by multivariate analysis for the characterization of adipose tissue aspirates from patients affected by systemic amyloidosis 114
A practical approach to the diagnosis of systemic amyloidoses 114
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils 113
Bone marrow amyloidosis. 113
A prospective, controlled, non-randomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple myeloma. 112
Hereditary amyloidosis 112
Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: Avoiding misdiagnosis of a treatable hereditary neuropathy 112
Repurposing diflunisal for familial amyloid polyneuropathy: A randomized clinical trial 111
Biological variation of N-terminal pro-brain natriuretic peptide in healthy individuals. 110
Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine 110
Holter monitoring in AL amyloidosis: prognostic implications. 110
Patterns of relapse after upfront bortezomib therapy in AL amyloidosis 110
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. 110
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide 109
Characterization of the new serum protein reference material ERM-DA470k/IFCC: value assignment by immunoassay. 109
Biochemical markers in early diagnosis and management of systemic amyloidoses 108
Valore prognostico della presenza di disturbi della conduzione cardiaca nei pazienti affetti da amiloidosi AL 106
Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis 106
Correlation between serum concentrations of N-terminal natriuretic peptide type B (NT-proBNP) and troponin-I (TnI) in AL amyloidosis 106
Thalidomide plus intermediate-dose dexametasone is an effective but toxic treatment for patients with AL (primary) amyloydosis 106
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 106
Single-molecule real-time sequencing of the M protein: Toward personalized medicine in monoclonal gammopathies 105
Utility of biochemicalmarkers in the follow-up of heart transplant recipients 105
AMICA: an electronic patient record specifically designed for an amyloidosis network. 105
Diagnostic performance of triggering receptor expressed on myeloid cells-1 and CD64 index as markers of sepsis in preterm newborns 105
Investigating heart-specific toxicity of amyloidogenic immunoglobulin light chains: A lesson from C. elegans 105
In situ characterization of protein aggregates in human tissues affected by light chain amyloidosis: a FTIR microspectroscopy study 105
Prognostication of survival and progression to dialysis in AA amyloidosis 105
Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation 105
Comparison of three strategies for myocardial protection during coronary artery bypass graft surgery based on markers of cardiac damage. 104
Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis 104
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 104
Pharmacokinetic behavior of Rituximab: a study of different schedules of administration for heterogeneous clinical settings. 104
Totale 12.040
Salva come PNG Salva come JPEG
Categoria #
all - tutte 187.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.716
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021665 0 0 0 0 0 0 0 0 0 339 264 62
2021/20222.073 28 13 56 25 42 59 34 143 128 72 317 1.156
2022/20236.981 815 460 81 552 667 735 22 375 2.973 38 156 107
2023/20242.324 289 458 101 200 259 538 41 145 21 63 121 88
2024/20256.414 135 574 179 216 112 323 231 398 1.636 231 757 1.622
2025/202615.048 1.203 1.186 1.714 1.880 2.070 727 3.162 684 1.478 944 0 0
Totale 43.248